CEO & Managing Director
Mr. Arun Sawhney joined Ranbaxy in May 2008 and was elevated to the position of President-Global Pharmaceutical Business in January 2010. He was appointed as Managing Director of the Company effective August 20, 2010, for a period of three years, and re-designated as CEO & Managing Director effective August 5, 2011. He was re-appointed as CEO & Managing Director of the Company for a period of five years effective January 1, 2012.
Mr. Sawhney is an industry veteran, with over three decades of international experience in the Chemical and Pharmaceutical arena. He has held senior functional and management positions in global pharmaceutical companies like Max-Gb, Hindustan Ciba-Geigy, Bayer India Limited and Dr. Reddy’s Laboratories Limited.
Mr. Sawhney is one of the founder members of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) and is currently a member of the Advisory Board of the United States Pharmacopeia (USP) in India. He is also the Chairman of the Confederation of Indian Industry (CII)’s National Committee on Drugs & Pharmaceuticals and a Member of the India-Malaysia CEOs Forum, the India-South Africa CEOs Forum, the India-Russia CEOs Forum and the India Africa Business Council constituted by the Government of India. Mr. Sawhney has been Chairman of the Pharmaceutical Committee of the Federation of Indian Chambers of Commerce and Industry (FICCI). He is also a member of the Academic Advisory Council of the International Management Institute (IMI), Delhi, India.
An alumnus of IMI, he graduated in Commerce from the Sydenham College of Commerce, Mumbai, India.